Sayana Press Brings Affordable Family Planning to 69 Countries

Lack of contraception and family planning services is a serious challenge for women in developing countries around the world. According to the World Health Organization (WHO), more than 200 million women in the Global South would like to access contraception, but are currently unable. In 2012 alone, this led to almost 80 million unplanned pregnancies, with about 25% of women resorting to unsafe abortions.

Continue reading

Aponjon Offers Personalized mHealth Messages to Pregnant Women

  When families find out that they are pregnant, they usually do whatever they can to understand how to provide the ensure the best antenatal development. Some resort to books offering a multitude of advice and regulations, others seek the advice of medical practitioners. Where neither of these resources are readily available people sometimes resort to advice from people in …

Continue reading

Innovative Partnership Strengthens Home-Grown Health Care

A collaboration between PATH and the South African Medical Research Council (SAMRC) has established an innovative health centre to fast-track the development of a number of sustainable health technologies that are aimed specifically at reducing maternal and child deaths in the country and in low-income communities in particular.

Continue reading

All-In-One Injectable Contraceptives

Access to adequate family planning services is critical in the Global South where an estimated one-third of all maternal deaths could be prevented by allowing women to plan their pregnancies. Injectable contraceptives are a common birth control method for women worldwide but they need to be routinely administered in a clinic and, as a result, are not always accessible to …

Continue reading

New Drug Could Combat Postpartum Maternal Deaths

Childbirth complications are a leading cause of death for women in the Global South. According to the World Health Organization (WHO), 130,000 women are killed annually as a result of postpartum hemorrhage (PPH). An upcoming clinical trial seeks to curb maternal deaths with the introduction of a new drug that prevents excessive post-childbirth bleeding. The trial, set to launch in …

Continue reading